26 Ott Copy number analysis of the BIRC3 gene by droplet digital PCR in chronic lymphocytic leukemia patients with 11q deletion Posted at 13:03h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Caterina Ilari Read More
26 Ott Extracellular vesicles as GVHD biomarkers Posted at 13:00h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Giuseppe Lia Read More
26 Ott Comprehensive characterization of plasmatic exosomes in pediatric anaplastic large-cell lymphoma: new tools for monitoring cancer progression Posted at 12:59h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Federica Lovisa Read More
26 Ott Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients Posted at 12:57h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Olivia Marini Read More
26 Ott The genomic evolution of high-risk smoldering multiple myeloma Posted at 12:55h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Francesco Maura Read More
26 Ott Clinical and pathogenetic features of ETV6 related thrombocytopenia with predisposition to acute lymphoblastic leukemia Posted at 12:54h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Federica Melazzini Read More
26 Ott VMP versus Rd schedules in elderly multiple myeloma Posted at 12:53h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Francesco Mendicino Read More
26 Ott The BCR/ABL1-like predictor: a new Q-RT-PCR-based tool to identify adult BCR/ABL1-like acute lymphoblastic leukemia cases Posted at 12:51h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Monica Messina Read More
26 Ott An integrated analysis of cardio-vascular adverse events of carfilzomib, cyclophosphamide and dexamethasone in elderly newly diagnosed myeloma patients enrolled in 3 phase I/II trials Posted at 12:47h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Roberto Mina Read More
26 Ott Minimal residual disease assessment may drive consolidation therapy in acute myeloid leukemia Posted at 12:44h in Comunicazioni orali 2016 by Anna Scotti (staff) 0 Comments 0 Likes Paola Minetto Read More
